CD44 as a novel target for treatment of staphylococcal enterotoxin B-induced acute inflammatory lung injury

Clinical Immunology

Volumn 144, Issue 1, 2012, Pages 41-52

  Sun, Jingping ^a   Law, Gabriela P ^a   Bridges, Christy C ^a   McKallip, Robert J ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD44; Lung inflammation; ; Staphylococcal enterotoxin B;

Indexed keywords

CD44 MONOCLONAL ANTIBODY; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CELL COUNT; CELL EXPANSION; CELL INFILTRATION; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE DELETION; INFLAMMATORY CELL; KNOCKOUT MOUSE; LEUKOCYTE; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RESPIRATORY DISTRESS SYNDROME; SPLEEN CELL; T LYMPHOCYTE; WILD TYPE;

ACUTE LUNG INJURY; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CYTOKINES; ENTEROTOXINS; EPITHELIAL CELLS; FEMALE; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA; SPLEEN;

EID: 84861567719     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.05.001     Document Type: Article

References (52)

1. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., Harrison L.H., Lynfield R., Dumyati G., Townes J.M., Craig A.S., Zell E.R., Fosheim G.E., McDougal L.K., Carey R.B., Fridkin S.K. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
2. Strandberg K.L., Rotschafer J.H., Vetter S.M., Buonpane R.A., Kranz D.M., Schlievert P.M. Staphylococcal superantigens cause lethal pulmonary disease in rabbits. J. Infect. Dis. 2010, 202:1690-1697.
3. McKallip R.J., Fisher M., Do Y., Szakal A.K., Gunthert U., Nagarkatti P.S., Nagarkatti M. Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes. J. Biol. Chem. 2003, 278:43818-43830.
4. Madsen J.M. Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clin. Lab. Med. 2001, 21:593-605.
5. van Weering D.H., Baas P.D., Bos J.L. A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl. 1993, 3:100-106.
6. Goodison S., Urquidi V., Tarin D. CD44 cell adhesion molecules. Mol. Pathol. 1999, 52:189-196.
7. Galandrini R., Albi N., Tripodi G., Zarcone D., Terenzi A., Moretta A., Grossi C.E., Velardi A. Antibodies to CD44 trigger effector functions of human T cell clones. J. Immunol. 1993, 150:4225-4235.
8. Tan P.H., Santos E.B., Rossbach H.C., Sandmaier B.M. Enhancement of natural killer activity by an antibody to CD44. J. Immunol. 1993, 150:812-820.
9. Clark R.A., Alon R., Springer T.A. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J. Cell Biol. 1996, 134:1075-1087.
10. DeGrendele H.C., Estess P., Siegelman M.H. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997, 278:672-675.
11. Hollingsworth J.W., Li Z., Brass D.M., Garantziotis S., Timberlake S.H., Kim A., Hossain I., Savani R.C., Schwartz D.A. CD44 regulates macrophage recruitment to the lung in lipopolysaccharide-induced airway disease. Am. J. Respir. Cell Mol. Biol. 2007, 37:248-253.
12. Jameson J.M., Cauvi G., Sharp L.L., Witherden D.A., Havran W.L. Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation. J. Exp. Med. 2005, 201:1269-1279.
13. Khan A.I., Kerfoot S.M., Heit B., Liu L., Andonegui G., Ruffell B., Johnson P., Kubes P. Role of CD44 and hyaluronan in neutrophil recruitment. J. Immunol. 2004, 173:7594-7601.
14. Dimitroff C.J., Lee J.Y., Fuhlbrigge R.C., Sackstein R. A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:13841-13846.
15. Dimitroff C.J., Lee J.Y., Rafii S., Fuhlbrigge R.C., Sackstein R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J. Cell Biol. 2001, 153:1277-1286.
16. Hidalgo A., Peired A.J., Wild M.K., Vestweber D., Frenette P.S. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 2007, 26:477-489.
17. Katayama Y., Hidalgo A., Chang J., Peired A., Frenette P.S. CD44 is a physiological E-selectin ligand on neutrophils. J. Exp. Med. 2005, 201:1183-1189.
18. Blass S.L., Pure E., Hunter C.A. A role for CD44 in the production of IFN-gamma and immunopathology during infection with Toxoplasma gondii. J. Immunol. 2001, 166:5726-5732.
19. Campo G.M., Avenoso A., Campo S., D'Ascola A., Nastasi G., Calatroni A. Small hyaluronan oligosaccharides induce inflammation by engaging both toll-like-4 and CD44 receptors in human chondrocytes. Biochem. Pharmacol. 2010, 80:480-490.
20. Fujii K., Tanaka Y., Hubscher S., Saito K., Ota T., Eto S. Crosslinking of CD44 on rheumatoid synovial cells augment interleukin 6 production. Lab. Invest. 1999, 79:1439-1446.
21. Mustafa A., McKallip R.J., Fisher M., Duncan R., Nagarkatti P.S., Nagarkatti M. Regulation of interleukin-2-induced vascular leak syndrome by targeting CD44 using hyaluronic acid and anti-CD44 antibodies. J. Immunother. 2002, 25:476-488.
22. Katoh S., Matsumoto N., Kawakita K., Tominaga A., Kincade P.W., Matsukura S. A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J. Clin. Invest. 2003, 111:1563-1570.
23. Hasan Z., Palani K., Rahman M., Thorlacius H. Targeting CD44 expressed on neutrophils inhibits lung damage in abdominal sepsis. Shock 2011, 35:567-572.
24. Garantziotis S., Li Z., Potts E.N., Kimata K., Zhuo L., Morgan D.L., Savani R.C., Noble P.W., Foster W.M., Schwartz D.A., Hollingsworth J.W. Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice. J. Biol. Chem. 2009, 284:11309-11317.
25. Liang J., Jiang D., Griffith J., Yu S., Fan J., Zhao X., Bucala R., Noble P.W. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J. Immunol. 2007, 178:2469-2475.
26. Nishiyama T., Mishima K., Ide F., Yamada K., Obara K., Sato A., Hitosugi N., Inoue H., Tsubota K., Saito I. Functional analysis of an established mouse vascular endothelial cell line. J. Vasc. Res. 2007, 44:138-148.
27. Udaka K. Proc. Soc. Exp. Biol. Med. 1970, 133:1384.
28. Rafi A.Q., Zeytun A., Bradley M.J., Sponenberg D.P., Grayson R.L., Nagarkatti M., Nagarkatti P.S. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. J. Immunol. 1998, 161:3077-3086.
29. Rafi-Janajreh A.Q., Chen D., Schmits R., Mak T.W., Grayson R.L., Sponenberg D.P., Nagarkatti M., Nagarkatti P.S. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J. Immunol. 1999, 163:1619-1627.
30. McKallip R.J., Fisher M., Do Y., Szakal A.K., Gunthert U., Nagarkatti P.S., Nagarkatti M. Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by IL-2 activated cytolytic lymphocytes. J. Biol. Chem. 2003, 278:43818-43830.
31. Ader F., Jawhara S., Nseir S., Kipnis E., Faure K., Vuotto F., Chemani C., Sendid B., Poulain D., Guery B. Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model. Crit. Care 2011, 15:R150.
32. Kwak Y.G., Song C.H., Yi H.K., Hwang P.H., Kim J.S., Lee K.S., Lee Y.C. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest. 2003, 111:1083-1092.
33. Tate M.D., Ioannidis L.J., Croker B., Brown L.E., Brooks A.G., Reading P.C. The role of neutrophils during mild and severe influenza virus infections of mice. PLoS One 2011, 6:e17618.
34. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
35. McKallip R.J., Lombard C., Sun J., Ramakrishnan R. Plumbagin-induced apoptosis in lymphocytes is mediated through increased reactive oxygen species production, upregulation of Fas, and activation of the caspase cascade. Toxicol. Appl. Pharmacol. 2010, 247:41-52.
36. Kotzin B.L., Leung D.Y., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv. Immunol. 1993, 54:99-166.
37. Proft T., Fraser J.D. Bacterial superantigens. Clin. Exp. Immunol. 2003, 133:299-306.
38. Sun J., Law G.P., McKallip R.J. Role of CD44 in lymphokine-activated killer cell-mediated killing of melanoma. Cancer Immunol. Immunother. 2011, 61:323-334.
39. Bao W., Fu H.J., Xie Q.S., Wang L., Zhang R., Guo Z.Y., Zhao J., Meng Y.L., Ren X.L., Wang T., Li Q., Jin B.Q., Yao L.B., Wang R.A., Fan D.M., Chen S.Y., Jia L.T., Yang A.G. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology 2011, 141:2076-2087. (e6).
40. Bollyky P.L., Falk B.A., Long S.A., Preisinger A., Braun K.R., Wu R.P., Evanko S.P., Buckner J.H., Wight T.N., Nepom G.T. CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. J. Immunol. 2009, 183:2232-2241.
41. Bourcier S., Sansonetti A., Durand L., Chomienne C., Robert-Lezenes J., Smadja-Joffe F. CD44-ligation induces, through ERK1/2 pathway, synthesis of cytokines TNF-alpha and IL-6 required for differentiation of THP-1 monoblastic leukemia cells. Leukemia 2010, 24:1372-1375.
42. Johnson P., Ruffell B. CD44 and its role in inflammation and inflammatory diseases. Inflamm. Allergy Drug Targets 2009, 8:208-220.
43. Fujii K., Tanaka Y., Hubscher S., Saito K., Ota T., Eto S. Cross-linking of CD44 on rheumatoid synovial cells up-regulates VCAM-1. J. Immunol. 1999, 162:2391-2398.
44. Fujii Y., Fujii K., Nakano K., Tanaka Y. Crosslinking of CD44 on human osteoblastic cells upregulates ICAM-1 and VCAM-1. FEBS Lett. 2003, 539:45-50.
45. Hagg D., Sjoberg S., Hulten L.M., Fagerberg B., Wiklund O., Rosengren A., Carlsson L.M., Boren J., Svensson P.A., Krettek A. Augmented levels of CD44 in macrophages from atherosclerotic subjects: a possible IL-6-CD44 feedback loop?. Atherosclerosis 2007, 190:291-297.
46. Sconocchia G., Campagnano L., Adorno D., Iacona A., Cococcetta N.Y., Boffo V., Amadori S., Casciani C.U. CD44 ligation on peripheral blood polymorphonuclear cells induces interleukin-6 production. Blood 2001, 97:3621-3627.
47. Liang J., Jiang D., Jung Y., Xie T., Ingram J., Church T., Degan S., Leonard M., Kraft M., Noble P.W. Role of hyaluronan and hyaluronan-binding proteins in human asthma. J. Allergy Clin. Immunol. 2011, 128:403-411. (e3).
48. Li Z., Potts E.N., Piantadosi C.A., Foster W.M., Hollingsworth J.W. Hyaluronan fragments contribute to the ozone-primed immune response to lipopolysaccharide. J. Immunol. 2010, 185:6891-6898.
49. Miyakawa H., Sato K., Shinbori T., Okamoto T., Gushima Y., Fujiki M., Suga M. Effects of inducible nitric oxide synthase and xanthine oxidase inhibitors on SEB-induced interstitial pneumonia in mice. Eur. Respir. J. 2002, 19:447-457.
50. Uchiyama H., Dobashi Y., Ohkouchi K., Nagasawa K. Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid. J. Biol. Chem. 1990, 265:7753-7759.
51. Zelko I.N., Folz R.J. Extracellular superoxide dismutase attenuates release of pulmonary hyaluronan from the extracellular matrix following bleomycin exposure. FEBS Lett. 2010, 584:2947-2952.
52. Stamenkovic I., Amiot M., Pesando J.M., Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989, 56:1057-1062.